KS

Kedar Nath Senapati - Profile

Kedar Nath Senapati, Whole-Time Director and Director, with 14 companies.

About Kedar Nath Senapati

Kedar Nath Senapati has 4 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 8 companies, including Skisen Labs Private Limited and Softdeal Pharmaceutical Private Limited. Formerly with 6 companies, such as Caraco Pharmaceuticals Private Limited and Neetnav Real Estate Private Limited. Engaged in General Business. Contributes to corporate operations.

Current Companies 8
Past Companies 6
Total Affiliations 14
Oldest Company Age 27
Companies Associated with Kedar Nath Senapati
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Kedar Nath Senapati?

Kedar Nath Senapati has 4 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 8 companies, including Skisen Labs Private Limited and Softdeal Pharmaceutical Private Limited. Formerly with 6 companies, such as Caraco Pharmaceuticals Private Limited and Neetnav Real Estate Private Limited. Engaged in General Business. Contributes to corporate operations.

What is Kedar Nath Senapati's role in current companies?

Kedar Nath Senapati is associated with 8 companies as Whole-Time Director and Director.

What industries does Kedar Nath Senapati specialize in?

Kedar Nath Senapati has expertise in General Business.

How many years of experience does Kedar Nath Senapati have?

Kedar Nath Senapati has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available